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This review from the International Consortium on Hallucinations Research intends to 
question the pertinence of the excitatory-to-inhibitory (E/I) imbalance hypothesis as a model for 
hallucinations. A large number of studies suggest that subtle impairments of the E/I balance are 
involved in neurological and psychiatric conditions, such as schizophrenia. Emerging evidence also 
points to a role of the E/I balance in maintaining stable perceptual representations, suggesting it may 
be a plausible model for hallucinations. In supports, hallucinations have been linked to inhibitory 
deficits as shown with impairment of Gamma-AminoButyric Acid transmission, N-Methyl-D-Aspartate 
receptor plasticity, reductions in gamma-frequency oscillations, hyperactivity in sensory cortices and 
cognitive inhibition deficits. However, the mechanisms by which E/I dysfunctions at the cellular level 
might relate to clinical symptoms and cognitive deficits remain unclear. Given recent data advances 
in the field of clinical neuroscience, it is now possible to conduct a synthesis of available data 
specifically related to hallucinations. These findings are integrated with the latest computational 
frameworks of hallucinations, and recommendations for future research are provided. 
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1 
2 
3 INTRODUCTION 
4 
5 
6 
7 Neural circuits are regulated by activity-dependent feedback systems that act to maintain a 
8 
9 precise excitatory-to-inhibitory (E/I) balance. This E/I balance has been shown to play an important 
10 
11 role in the  development  and  maintenance  of stable  perceptual representations
1
, suggesting  a 
12 
13 plausible link with hallucinations. In support, many studies have shown that inhibitory deficits are 
14 
15 linked with hallucinations. Inhibition, however, is a polysemic term with multiple meanings and 
16 
17 
functions. For example, not all the cognitive mechanisms falling under the rubric of inhibition may be 
18 
19 
meaningfully related to hallucinations
2
. In this paper, we first review evidence for potential inhibitory 
21 
22 dysfunction in (auditory and visual) hallucinations at different scales of understanding (i.e. molecular 
23 
24 level, system-level, cognitive level). Given that hallucinations are a clinical feature of schizophrenia 
25 
26 (SCZ), that literature is also reviewed so that deficits specific to hallucinations may be separated from 
27 
28 those general to SCZ. Evidence drawn from studies in other conditions in which hallucinations occur 
29 
30 
is also provided. Second, we amalgamate this understanding with the latest computational models. 
31 
32 
33 
Computational scale-free frameworks can provide powerful models for understanding hallucinations 
34 
35 by allowing the integration of macro-scale findings with micro-scale factors that dictate the E/I 
36 
37 balance. This knowledge carries potentially important information for understanding mechanisms of 
38 
39 hallucinations, and recommendations for future research and practice in the field are provided in the 
40 
41 last section. 
42 
43 
44 
45 
46 
47 
48 MOLECULAR AND PHARMACOLOGICAL EVIDENCE 
49 
50 
51 Decreased inhibition or increased excitation is now a consistent finding in SCZ. Genetic
3
, 
52 
53 physiological4,   5,  and  post-mortem6   evidence  converge  to  show  an  impairment  of  Gamma- 
54 
55 
56 
AminoButyric Acid (GABA) transmission in SCZ. Using rodent models, the experimental blockage of 
57 
58 parvalbumin interneurons
7, or the suppression of their activity using optogenetic methods8, was 
59 
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1 
2 
3 shown to induce significant reductions in γ-oscillations, a finding which was replicated in humans 
4 
5 with SCZ4  (see also the Neurophysiology section). Interestingly, such reduced GABAergic inhibition 
6 
7 was related to perceptual deficits
9
, such as reduced vulnerability to contrast-contrast illusions
10
. 
8 
9 Furthermore, global Glutamate (Glu) receptor hypofunction (notably of the N-Methyl-D-Aspartate 
10 
11 
12 
receptor or NMDA-R) in animal models was shown to cause an increase in intrinsic pyramidal cell 
13 
14 excitability and a selective disruption of parvalbumin-expressing interneurons
11. 
15 
16 
17 Psychotomimetic models (e.g. models that mimics the symptoms of psychosis), especially 
18 
19 those  based  on  ketamine  (an  antagonist  agent  of  NMDA-R),  also  support  the  E/I  imbalance 
20 
21 hypothesis. SCZ-like symptoms (e.g. perceptual aberrations, delusional ideas, thought disorder and 
22 
23 changes in affect) have been described in healthy volunteers taking ketamine
12  
as well as in auto- 
24 
25 
immune anti-NMDA-R encephalitis13. Moreover, ketamine affects the intensity and integrity of the 
26 
27 
28 sensory experience
14
. For both auditory and visual perception, acuity is increased and background 
29 
30 stimuli become more salient
14-16. Specifically, the drug was shown to bind D2 receptors and induce 
31 
32 striatal  dopamine  release
17
,  even  if  blocking  D2  receptors  with  Haloperidol  prior  to  ketamine 
33 
34 administration does not block ketamine-induced symptoms12. 
35 
36 
37 Furthermore, ketamine does not routinely induce hallucinations, rather illusory percepts – 
38 
39 
alterations of stimuli that are actually present
18
. However, a recent report suggests that ketamine 
40 
41 
42 administration inside the MRI scanner (perhaps a form of sensory isolation) does induce auditory 
43 
44 verbal and musical hallucinations
19
. Contrary to ketamine, LSD and other serotonergic hallucinogens 
45 
46 induce  profound  visual  hallucinations,  together  with  altered  sense  of  self  and  time
20   
but  no 
47 
48 consistent delusions
21
. Serotonergic hallucinogens mainly act at 5-HT receptors. However, they also 
49 
50 impact  upon  glutamatergic  transmission22   (and  thus  the  E/I  balance),  especially  in  the  locus 
51 
52 
coeruleus23  and in frontal cortex24. 
53 
54 
55 
56 
57 
58 
59 
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1 
2 
3 BRAIN IMAGING EVIDENCE 
4 
5 
6 1. From hyperactivation to brain dysconnectivity 
7 
8 
9 Consistent with the notion of an E/I imbalance, metabolic and functional changes in speech- 
10 
11 related areas have been widely reported in functional brain imaging studies of SCZ patients with 
12 
13 hallucinations25.  Two  main  study  categories  can  be  distinguished:  (i)  trait  studies  (i.e.  studies 
14 
15 
16 
comparing hallucinators with non-hallucinators), and (ii) state studies (i.e. studies conducted during 
17 
18 the   occurrence   of   hallucinations   in   the   scanner).   Increased   activation   within   a   bilateral 
19 
20 frontotemporal  network  was  confirmed  by  coordinate-based  meta-analysis  of  the  auditory 
21 
22 hallucination (AH) state
26
. State studies conducted in non-clinical hallucinators also confirmed the 
23 
24 role  of  fronto-temporal   regions  in  these  experiences,  independently   of  the  SCZ  status27. 
25 
26 Parahippocampal signal fluctuations preceding hallucinations’ occurrences
28
,   as well as 
27 
28 
dysconnectivity patterns of the hippocampal complex during hallucinations29, tends to indicate a 
30 
31 possible link between hallucinations and memory systems (see also the Cognition section). 
32 
33 
34 Trait studies mainly explored verbal self-monitoring, verbal imagery and source memory
25. 
35 
36 These experiments showed that SCZ patients with AHs exhibit decreased activation within temporal, 
37 
38 cingulate, premotor and subcortical regions thought to subserve the above mentioned functions
30
. In 
39 
40 a recent study using a predictive learning task, aberrant resting activity was evidenced in auditory 
41 
42 
cortex as well as weakened responses to unexpected speech in patients with AHs
31
, suggesting 
43 
44 
45 auditory cortex prediction error dysfunction. 
46 
47 
48 Auditory hallucinations are also associated with impaired connectivity of large scale networks 
49 
50 at both the functional
32
, and structural level
33
. Functional connectivity between Wernicke’s area and 
51 
52 Broca’s areas for example, is shown disrupted during inner speech processing in SCZ patients who 
53 
54 hear voices
34
, in line with the ‘comparator model’ theory, positing that AHs are related to inner- 
55 
56 
speech  self-monitoring  impairments35-37.  Overall,  studies  conducted  in  SCZ  suggest  that  this 
57 
58 
59 
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1 
2 
3 dysconnectivity may rely at the micro-scale on impaired control of synaptic plasticity
38, notably of 
4 
5 NMDA-dependent plasticity39, 40. Importantly, the dysconnectivity hypothesis was recently applied to 
6 
7 specific symptoms such as hallucinations, e.g. comparing different SCZ subgroups that only differ on 
8 
9 their hallucination status29, 41, but also to hallucinators outside of this clinical spectrum42. Changes in 
10 
11 
12 
distributed functional connectivity networks were finally obtained when targeting the left temporo- 
13 
14 parietal junction with non-invasive brain stimulation techniques such as repetitive transcranial 
15 
16 magnetic stimulation
43
, or transcranial direct current stimulation
44
, with substantial impacts on AH 
17 
18 severity (see also the Neuromodulation section). 
19 
20 
21 2. Glutamate and MR spectroscopy 
22 
23 
24 Given that fMRI-BOLD activations correlate with increases in Glu concentrations
45
, we could 
25 
26 
expect that Glu abnormalities overlap with the above-mentioned increased in neuronal firing during 
27 
28 
AHs
26, 30, 46
. Studies show Glu concentration abnormalities in SCZ relative to healthy controls
47, 48
, but 
30 
31 very few studies have made the link to AHs. An exception is a recent study using a MR spectroscopy 
32 
33 (
1H-MRS) approach. Hugdahl et al.49  demonstrated reduced Glx levels (i.e. the sum of Glu and 
34 
35 Glutamine, Gln) in the posterior temporal lobe and the inferior frontal gyrus in SCZ participants 
36 
37 relative to healthy controls. A significant positive  correlation was also found between frontal- 
38 
39 
temporal Glx levels and hallucination severity (assessed with item P3 from the Positive and Negative 
40 
41 
42 Syndrome Scale, PANSS), while correlations with negative symptoms were close to zero. Interestingly, 
43 
44 the Glx levels were higher in patients that scored in the upper range of the P3 symptom range, which 
45 
46 was interpreted as linked with a glutamatergic hyper-activity, not inhibited by the corresponding 
47 
48 increase in GABA release. This would mean that AHs may be accompanied by Glu increase, rather 
49 
50 than Glu reduction. A recent meta-analysis of 1H-MRS in SCZ also suggested that illness phases were 
51 
52 
associated with different Glu profiles48. Increased metabolite concentration in the speech areas in 
53 
54 
the temporal lobe was also reported by Homan et al.
50  
when comparing hallucinating and non- 
56 
57 hallucinating  patients. 
58 
59 
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1 
2 
3 
4 
5 
6 NEUROPHYSIOLOGICAL EVIDENCE 
7 
8 
9 
10 1. Phase synchronisation 
11 
12 
13 Neurons have been shown to synchronise their oscillatory phase (‘phase synchronisation’) in 
14 
15 response to specific stimulus contexts51. This phenomenon depends critically on E/I balance and is 
16 
17 thought to provide a temporal code that underpins coherent perception, thought, and action (the 
18 
19 ‘binding problem’), which has now been observed within and between distributed brain structures 
20 
21 
during rest, encoding and higher-order cognition
52-54
. 
23 
24 
25 State-studies  have  typically  observed  increased  phase  synchronisation  in  the  auditory 
26 
27 cortices of SCZ subjects. Initial case reports linked AHs to increased γ-band activity in left auditory 
28 
29 cortex
55, 56
, while larger works have reported increased α-band synchrony between right and left 
30 
31 auditory cortices57, 58, and more recently of θ-band and γ-bands in left frontal and auditory cortices59. 
32 
33 Ford and colleagues
60 
found 150 ms prior to and until speech production that β-band synchronisation 
34 
35 
(~15 Hz) was larger over frontal cortex in HC compared to SCZ; the degree of synchrony in controls 
36 
37 
38 was positively correlated with the degree of auditory N1 amplitude suppression resulting from 
39 
40 corollary discharge (N1 amplitude during talking versus listening), while in SCZ lower synchronisation 
41 
42 was related to AH severity. 
43 
44 
45 Several  trait-studies  have  examined  neural  synchronisation  using  auditory  steady-state 
46 
47 response (ASSR) paradigms. Spencer and colleagues61 found that 40 Hz stimulation elicited reduced 
48 
49 
gamma-band synchronisation in left auditory cortex of SCZ compared to HC, but was modulated by δ- 
50 
51 
52 
band (2 Hz) activity in SCZ. The degree of gamma-band synchronisation was also related to the 
53 
54 lifetime experience of AHs in SCZ. Reanalysing the same data, Mulert and colleagues
62  
found that 
55 
56 greater synchronisation between bilateral primary auditory cortices was correlated with AH severity 
57 
58 in patients. 
59 
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1 
2 
3 Using 20, 30 and 40 Hz stimulation, Koenig and colleagues
63 found that a global measure of 
4 
5 phase-locking  was  increased during  ASSR  stimulation in  non-AH patients  and healthy subjects 
6 
7 (especially at 40 Hz), but was decreased in AH patients, notably in the left hemisphere. Using a 
8 
9 similar paradigm, Hirano and colleagues64 also found that phase-locking was significantly reduced in 
10 
11 
12 
SCZ compared to controls at 40Hz only, however non phase-locked mean gamma-band power 
13 
14 (amplitude) was not different between the groups at rest and was increased during 40 Hz ASSR 
15 
16 stimulation in SCZ. Also in SCZ, AH symptoms were positively correlated with induced 40 Hz gamma- 
17 
18 band power in left hemisphere and negatively correlated with the ASSR stimulation phase-locking 
19 
20 factor. 
21 
22 
23 2. Sensory gating 
24 
25 
26 
Sensory  gating,  a  form  of  pre-attentional  inhibition  when  facing  repeated  sensory 
27 
28 
29 stimulation, is usually examined with pairs of stimuli (S1 and S2) presented at some stimulus-onset- 
30 
31 asynchrony (SOA). In healthy subjects, a positive wave peaking ~50 ms after each stimulus (P50), 
32 
33 exhibits reduced amplitude to S2 compared to S1; the S2:S1 ‘gating-ratio’ of P50 amplitudes is the 
34 
35 dependent measure in clinical studies. Acutely psychotic and non-psychotic SCZ patients exhibit 
36 
37 larger  P50  gating-ratios  than  healthy  controls  (especially  when  SOA=500  ms),  irrespective  of 
38 
39 
medication status
65, 66
. This deficit is also observed in about half of SCZ relatives
67
, indicating that a 
40 
41 
42 P50 gating-ratio deficit may be a endophenotypic marker for vulnerability to SCZ. 
43 
44 
45 Two studies have explored the role of impaired sensory gating in AHs. Using a standard 
46 
47 paradigm, Smith and co-workers
68  observed greater P50 in SCZ with drug-resistant hallucinations 
48 
49 compared to healthy controls, and SCZ ratios exhibited a positive correlation with lifetime AH scores 
50 
51 (from the PSYRATS) but not current AH scores (from the PANSS). In contrast, Hirano and colleagues69 
52 
53 found that the magnetic P50 (P50m) gating-ratio analogue observed in response to pairs of a 
54 
55 
56 
Japanese vowel sound (SOA=500 ms), was larger in the left hemisphere in SCZ compared to healthy 
57 
58 
59 
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1 
2 
3 controls, and was positively correlated with current AH scores, however not all SCZ had drug- 
4 
5 resistant  hallucinations. 
6 
7 
8 3. Neuromodulation studies 
9 
10 
11 Combining Transcranial Magnetic Stimulation (TMS) with electroencephalography (EEG) and 
12 
13 
electromyography (EMG) constitutes a powerful tool to assess the E/I balance in humans
70,  71
. 
14 
15 
16 Numerous   studies   have   investigated   excitatory   and   inhibitory   mechanisms   in   medicated, 
17 
18 unmedicated, first episode patients with schizophrenia and subjects at risk to develop SCZ
72
, but only 
19 
20 few studies have investigated their relationship with AHs. 
21 
22 
23 Most of paired-pulse TMS paradigm applied over the motor cortex investigating NMDA 
24 
25 glutamate receptor activity failed to demonstrate any difference between SCZ patients and healthy 
26 
27 controls73, 74. No studies directly explored the relationship between AHs and excitatory mechanisms 
28 
29 measured by paired-pulse TMS paradigm applied over the motor cortex. Investigating the parieto- 
30 
31 
motor connectivity with a subthreshold preconditioning pulse over the posterior parietal cortex 
32 
33 
34 before the test pulse over the ipsilateral motor cortex, a study reported reduced paired pulse 
35 
36 facilitation in patients with SCZ
75. Even if such facilitatory interactions are thought to depend on the 
37 
38 superior longitudinal fasciculus integrity, a white matter tract associated to AHs’ severity
76, patients 
39 
40 with lower negative symptoms had less impaired parieto-motor connectivity
75
. 
41 
42 
43 Short-interval cortical inhibition (SICI) is a paired-pulse paradigm with 1-4 ms interstimulus 
44 
45 intervals associated with the GABA-A receptor-mediated inhibitory neurotransmission
77
. A recent 
46 
47 meta-analysis73  reported that SICI was significantly reduced in SCZ patients when compared with 
48 
49 healthy subjects (d = 0.476). Daskalakis and colleagues reported that the intensity of the SICI deficit 
50 
51 
correlated with the intensity of positive symptoms78. Investigating integrity of the cerebello-thalamo- 
53 
54 cortical loop with a TMS pulse delivered over the cerebellum 5-15 ms before a TMS pulse applied 
55 
56 over the contralateral primary motor cortex, a study also reported reduced cerebellar inhibition in 
57 
58 SCZ patients79. Even if cerebellar dysfunction has been linked with confusion between reality and 
59 
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1 
2 
3 perceived reality, leading to positive psychotic thinking
80, the relationship between the severity of 
4 
5 AHs and the intensity of the cerebellar inhibition deficit has yet to be explored. 
6 
7 
8 Combining TMS and EEG, Farzan and colleagues
81  
reported that patients with SCZ had 
9 
10 significant deficits in the inhibition of gamma oscillations in the dorsolateral prefontal cortex (DLPFC), 
11 
12 a phenomenon known associated with an impairment in GABA-B receptor mediated inhibition. The 
13 
14 severity of this deficit correlated with the illness severity as measured by the BPRS. However, the 
15 
16 
specific link with AHs was not investigated. Interestingly, using tDCS, a recent study also investigated 
18 
19 the excitability of the occipital cortex in healthy subjects, and reported a correlation between the 
20 
21 predisposition to anomalous experiences/ hallucinations score measured by the Cardiff Anomalous 
22 
23 Perceptions Scale (CAPS)
82 
and the number of visual distortions that occurred from viewing aversive 
24 
25 gratings during active and sham tDCS83. This suggests a hyperexcitability of the brain in clinical and 
26 
27 non-clinical subjects predisposed to hallucinate. 
28 
29 
30 
31 
32 
33 COGNITION 
34 
35 
36 
37 Inhibition  is  also  a  broad  psychological  construct  which  refers  to  a  particular  form  of 
38 
39 prefrontal executive control that assists a range of cognitive skills (i.e. attention, learning, memory 
40 
41 and language) and behaviours. The principal role of cognitive inhibition is to suppress irrelevant 
42 
43 information and previously activated cognitive contents, and resist interference from competing 
44 
45 stimuli84. Cognitive inhibition can be further differentiated into (i) interference control which refers to 
46 
47 
an initial perceptual stage of processing
85 
(assessed on tasks such as the Stroop task); (ii) automatic 
48 
49 
50 (or  unintentional)  inhibition,  referring  to  automatic,  preparatory,  and  prestimulus  processes
86
 
51 
52 (assessed with tasks such as Negative Priming paradigms
87
) and (iii) intentional inhibition which 
53 
54 applies to goal-directed and post-stimuli processes which may be conscious or unconscious
86,  88
 
55 
56 
57 
58 
59 
58 
59 
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1 
2 
3 (assessed with tasks such as the Hayling Sentence Completion Task (HSCT) or the Inhibition of 
4 
5 Currently Irrelevant Memories Task (ICIM)
89
). 
6 
7 
8 By definition, AH in SCZ are sensory experiences over which the person does not feel/ (s)he 
9 
10 has direct and voluntary control90, 91. Consequently, cognitive explanations of AH have suggested that 
11 
12 this reduced sense of control arises from a breakdown in inhibition
92
, and that such deficits might 
13 
14 
results in the emergence of irrelevant material from long-term memory into awareness93,  94. In 
16 
17 support, studies have showed that hallucination frequency was associated with difficulties on tasks 
18 
19 requiring the suppression of irrelevant information and distracting information on the ICIM and HSCT 
20 
21 tasks95, 96, a Directed Forgetting (DF) task97, and the Dichotic Listening task98, signalling deficits in 
22 
23 intentional inhibition. Such deficits were not found correlated with delusions or other symptom 
24 
25 dimension. Furthermore, negative findings were reported on the other inhibition constructs of 
26 
27 
interference control and  automatic inhibition
99-101   99,  102
, pointing to specific deficits in suppressing 
28 
29 
30 mental events that are activated, and held in working memory. This was also supported by recent 
31 
32 imaging studies showing that the morphology of the anterior cingulate cortex, known associated with 
33 
34 inhibitory control efficiency103, is also associated with AHs104. 
35 
36 
37 Two studies extended these results in non-clinical participants scoring high on measures of 
38 
39 hallucination-like experiences. Paulik et al.
105 
reported that these individuals made more false alarms 
40 
41 on ICIM  conditions  requiring intentional  inhibition  than comparison  controls.  This  finding  was 
42 
43 
partially  replicated  by  a  recent  paper
106
,  which  showed  correlations  with  ICIM  scores  with 
44 
45 
46 participants’ scores on one measure of hallucination-proneness (the Cardiff Anomalous Percepts 
47 
48 Scale; r = .38) but not with another (the Launay-Slade Hallucination Scale; r = .10). Thus, in both 
49 
50 clinical and non-clinical groups, there is evidence to suggest that the predisposition to hallucinate is 
51 
52 related to intentional inhibition abilities. 
53 
54 
55 Intentional inhibition deficits have also been examined in a number of other mental health 
56 
58 
59 
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32 
49 
 
 
 
1 
2 
3 compulsive  disorder  (OCD)
107-109   and  post-traumatic  stress  disorder  (PTSD)110-113,  providing  further 
4 
5 support for the role of inhibition in the control of unsolicited mental events. 
6 
7 
8 Inhibition and memory processes are very much intertwined, and executive control over many 
9 
10 cognitive constructs (ie. memory) also appears compromised in hallucinations. A deficient inhibitory 
11 
12 control system may produce inefficient learning, retention of inappropriate details, or irrelevant 
13 
14 
(intrusive) memories114, 115, whereas excessive inhibition may result in repression of memories116. A 
16 
17 particular feature of many intentional inhibition tasks on which individuals with AH are impaired (ie. 
18 
19 ICIM, DR, working memory task) is that they also involve memory processes, and require the 
20 
21 suppression of mental representation from memory stores. It has been suggested that hallucinations 
22 
23 may  involve  ‘parasitic  memories’
117,  118   
or  the  intrusions  of  strongly  activated  (but  irrelevant) 
24 
25 representations in memory93, 94, especially when words are negative or derogator119. 
26 
27 
28 
29 
30 
31 CONSIDERING    THESE FINDINGS    USING    SCALE-FREE    COMPUTATIONAL 
33 
34 APPROACHES 
35 
36 
37 
38 Building on the previous sections, the following considers how both micro- and macro-scale 
39 
40 findings on hallucinations can be convincingly articulated using computational modelling. Several 
41 
42 theoretical models have already been proposed to account for hallucinations120, 121. In this report, we 
43 
44 will mainly focus on Bayesian inference, but note that the different underlying hypotheses for these 
45 
46 models are not necessarily mutually exclusive but may instead be complementary, in that they bring 
47 
48 
different insights into the mechanisms behind hallucinations
122
. 
50 
51 
52 1.   The predictive coding framework 
53 
54 
55 Recent theories propose that hallucinations could be due to altered inference mechanisms
123-
 
56 
57 
125
. Originating from Helmholtz’ idea of unconscious inference
126
, these theories conceptualize the 
60 Page 13 of 21  
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1 
2 
3 brain as an inference machine that uses learned predictions (prior beliefs), combined with sensory 
4 
5 evidence, to infer the causes of the incoming sensory data (‘posterior probabilities’). Importantly, 
6 
7 both the prior and the sensory evidence are weighted by their precisions, which define their relative 
8 
9 contributions on the ‘posterior’. 
10 
11 
12 
A plausible implementation of Bayesian inference in the brain is hierarchical predictive 
14 
15 coding
127-130. The core idea is that an internal model that represents the knowledge about the outer 
16 
17 world serves to generate a stable perceptual experience despite noisy sensory data. Predictive 
18 
19 signals are thought to be fed-back from higher to lower levels of the cortical hierarchy. When these 
20 
21 predictions are violated by the sensory data, a precision-weighted prediction error signal is fed- 
22 
23 forward to the next hierarchical level to update the predictive model and drive learning. If the 
24 
25 
precision of the sensory data is high relative to the precision of the prior belief, the prediction error 
26 
27 
28 will be greater, and vice versa. It has been proposed that psychosis is linked to increased prediction 
29 
30 error  signaling
123   which  in  turn  leads  to aberrant  salience  and  the  formation  of  delusions,  as 
31 
32 proposed earlier
124, 125, 131-133
. 
33 
34 
35 Disrupted predictive coding has also been invoked as a mechanism underlying hallucinations 
36 
37 per se123-125. Different predictive coding alterations have been proposed. One possibility is that 
38 
39 
hallucinations result from an overly strong effect of top-down predictive signals on neural activity in 
40 
41 
sensory cortices134,  135. Others have linked hallucinations to a failure to attenuate the sensory 
43 
44 consequences of inner speech, in analogy to the mechanism that is thought to underlie delusions of 
45 
46 control
40,  125,  136
. In Bayesian inference terms, the latter mechanism would correspond to increased 
47 
48 prediction errors, possibly resulting from neural signals that encode inner speech in auditory cortex 
49 
50 with relatively high precision123, 137. Even if compatible with the E/I imbalance hypothesis, how this 
51 
52 
expectation gives rise to voices rather than other sounds remains to be established138. 
53 
54 
55 
56 
57 
58 
59 
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1 
2 
3 2.   The circular inference framework 
4 
5 
6 The prediction coding hypothesis suggesting that SCZ subjects give too much relative weight 
7 
8 to their prior beliefs may have some limitations, especially when considering the fact that patients 
9 
10 with psychosis are less sensitive to many perceptual illusions than healthy individuals10, 139-141, which 
11 
12 is inconsistent with the proposition that strong priors would be at the root of perceptual illusions
142,
 
13 
14 143. To overcome these shortcomings, it could be useful to come back to a mathematically rigorous 
16 
17 formulation of hierarchical causal inference. In a Bayesian network, inference can be performed by a 
18 
19 recurrent propagation of messages between causal nodes in all possible directions: top down, 
20 
21 bottom up, and laterally. Inference is only complete after all such messages have been sent in the 
22 
23 cortical hierarchy
144
. Since long-range connections in the brain are overwhelmingly excitatory, these 
24 
25 messages would be reverberated endlessly through feed-forward/feedback excitatory loops if they 
26 
27 
were not controlled by the presence of equivalently strong inhibitory connections. Indeed such 
28 
29 
30 balance is tightly maintained in cortical networks, and was shown affected in SCZ
145. Scaling down 
31 
32 inhibition (or scaling up excitation) in such a computational model results in a pathological form of 
33 
34 inference called "Circular Belief Propagation", in which “bottom-up” and “top-down” messages are 
35 
36 reverberated and taken into account multiple times146. 
37 
38 
39 Even when facing weak sensory evidence, circular propagation generates strong perceptual 
40 
41 beliefs: hallucinations occur where nothing relevant should have been inferred. In the same way, 
42 
43 circular inference introduces spurious correlations between feedforward and feedback messages 
44 
45 
that are non-existent in the real world. This leads to the learning and consolidation of “unshakable” 
46 
47 
48 (but false) causal relationships, resulting in delusional belief systems. In this line, hallucinations have 
49 
50 been proposed to originate primarily from the reverberation of “bottom-up” messages, leading to an 
51 
52 over-interpretation of the sensory evidence
146
. This does not rule out the possibility that some 
53 
54 individuals with hallucinations (within, but also beyond the SCZ spectrum) may over-interpret their 
55 
56 
57 
58 
59 
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1 
2 
3 priors
134, 147. Importantly, these two hypotheses could be tested experimentally by measuring how 
4 
5 patients weight their likelihood and priors during decisions. 
6 
7 
8 3.     Further experimental support 
9 
10 
11 Besides   the   clinical   and   cognitive   predictions   of   these   models,   several   neural 
12 
13 implementations have been proposed
127, 128, 144, 148-151
. Regardless of its specific implementation, it is 
14 
15 
important to consider that belief propagation relies on local inhibitory control to avoid circular 
16 
17 
18 inference. The presence of these corrective connections has been shown to be highly compatible 
19 
20 with the architecture, connectivity and dynamics of the cortical column
152. In such a context, it can be 
21 
22 interesting to reappraise the effects of ketamine from an inferential point of view. Corlett et al. 
23 
24 suggested that under ketamine, the subject may experience both perceptual aberrations (due to 
25 
26 AMPA up-regulation) and a reduced capacity to accommodate and ignore these aberrations (due to 
27 
28 
NMDA blockade)
124
. This suggests that ketamine and PCP disturb the feed-forward mechanism 
29 
30 
31 (prediction error signal) through AMPA upregulation and the feedback constraint (priors) through 
32 
33 NMDA blockade. The impairment of NMDA function would limit the extent to which priors could 
34 
35 exert their effect in explaining the mismatch that is carried by the upregulated AMPA signaling. This 
36 
37 would lead to persistence of perceptual aberrations due in part to persistent AMPA signaling and in 
38 
39 part to an attenuation of the constraining effect that priors would normally afford on perception (see 
40 
41 
also19). Intriguingly, contrary to ketamine, LSD alters glutamatergic function but it does not impair 
42 
43 
NMDA signaling
22  
and may actually enhance it
153
. Thus, LSD induces more visual hallucinations, a 
45 
46 phenomenon that can be captured by circular inferences
122. 
47 
48 
49 
50 
51 
52 CONCLUSION AND RECOMMENDATIONS FOR FUTURE RESEARCH 
53 
54 
55 
56 Overall, this report reviewed the applicability of multi-scale approaches of hallucinations 
57 
58 presenting the current available data for an E/I imbalance in these experiences. Bayesian inference 
59 
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1 
2 
3 frameworks were shown to be particularly efficient for integrating various degrees of understanding, 
4 
5 from   the   molecular   to   anatomo-functional   or   behavioral   levels.   Three   main   lines   of 
6 
7 recommendations emerged from the working group. First in terms of population studied, it would be 
8 
9 particularly useful if future research could devote concerted efforts in exploring these hypotheses 
10 
11 
12 
transdiagnostically, to adequately control for the SCZ factor. Beyond simple group comparisons, 
13 
14 future cognitive studies could for example examine whether the magnitude of participant’s DF or 
15 
16 ICIM effect from different populations correlated with the number of intrusions they experience. This 
17 
18 would notably allow to test whether intentional inhibition problems cause the intrusive cognitions 
19 
20 reported  in  OCD  and  PTSD.  Second,  in  terms  of  paradigms,  multiscale  approaches  should  be 
21 
22 privileged, e.g. cognitive/ MRS. Some specific recommendations could notably be made regarding 
23 
24 
emerging exploratory methods, like MRS. Indeed, GABA measures from the same brain regions as are 
26 
27 targeted for measures of Glu could allow to sort out the specificity of E/I interactions for the 
28 
29 initiation and maintenance of hallucinations. The validation of these experimental data through 
30 
31 computational model fitting, based on predictive coding and circular inference frameworks, should 
32 
33 finally reinforce the biological plausibility of the computational approach. 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
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